Source BioScience's 2009 Revenues Rise 11 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Source BioScience this week reported that its full-year 2009 revenues grew 11 percent and the firm swung to a profit from a loss year over year.

The UK-based provider of diagnostic and life science research tools and services said that its full-year 2009 revenues were £12.7 million ($18.9 million) compared to £11.5 million for 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.